Talk:Tirapazamine
Appearance
This is the talk page for discussing improvements to the Tirapazamine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tirapazamine.
|
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
PubChem link, for later additions[1]. JFW | T@lk 08:35, 5 January 2006 (UTC)
- It turns out the tautomer registered on PubChem is not the most prevalent one. I have uploaded a more correct one at the suggestion of Prof. M. Brown (Martinbrown (talk · contribs)), who discussed this with Prof. W.A. Denny (see references and [2]). JFW | T@lk 20:01, 10 January 2006 (UTC)
Study results available
[edit]Results of the mentioned "Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer" are available now: http://www.onclive.com/conference-coverage/liver-2017/combinations-in-hcc-gaining-traction?p=1 — Preceding unsigned comment added by 47.68.124.250 (talk) 12:06, 22 April 2017 (UTC)